University of Manitoba
Winnipeg, Manitoba, R3E 0J9, Canada
Location status: Recruiting
Location contact
Kristine Cowley, PhD
CONTACT
Kristine Cowley, PhD
PRINCIPAL_INVESTIGATOR
Rodrigo Villar, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07692191
Our overall objective is to decrease the prevalence of multiple sedentary-related diseases that are secondary consequences of spinal cord injury (SCI). SCI affects motor, sensory and autonomic systems and can cause very limited exercise capacity which then leads to very high rates of obesity, metabolic syndrome, type II diabetes and cardiovascular disease.
This randomized controlled study aims to determine whether and how transcutaneous spinal electrical stimulation (TSES) alters acute (immediate) exercise responses in people living with SCI. Exercise responses will be tested during incremental tests to fatigue, and during steady state tests. Testing will occur over several study visits and results will be compared within each individual as well as between groups (tetraplegia and paraplegia) and to a group of reference controls. A number of outcomes will be monitored, including whole-body metabolic responses using a metabolic cart, muscle responses using EMG sensors and muscle oxygenation using near infrared spectroscopy (NIRS) sensors, time to fatigue, power output, as well as perceptions about fatigue and effort.
The findings of this study are expected to provide evidence regarding whether and how TSES might improve acute exercise responses in people living with SCI.
Interested in participating?
Request Info18 year–70 year
All sexes
Interventional
Not applicable
Winnipeg, Manitoba, R3E 0J9, Canada
Location status: Recruiting
Kristine Cowley, PhD
CONTACT
Kristine Cowley, PhD
PRINCIPAL_INVESTIGATOR
Rodrigo Villar, PhD
PRINCIPAL_INVESTIGATOR
It is well understood that SCI causes motor paralysis and sensory loss. However, it is the loss of autonomic regulation that confers the greatest morbidity to those living with SCI. Impaired exercise responses, including limited peak HR, oxygen uptake, limited catecholamine related to impaired activation of spinal sympathetic autonomic systems. Depending upon level of injury, and these sub-optimal exercise responses, there are limited exercise training effects which then leads to a calorie excess and related weight gain, cardiovascular, skeletal muscle and metabolic deconditioning that eventually causes obesity, type II diabetes and cardiovascular disease.
These sedentary-related diseases likely result in large part, because of inadequate activation of these tissues with sufficient duration or intensity to result in training effects. Therefore, we are interested in identifying means to improve acute exercise responses, with an ultimate goal of improving training responses and reducing the incidence of and/or trajectory of developing these sedentary-related diseases in individuals with SCI.
TSES has recently emerged as a potential therapeutic method to improve exercise responses. In case studies it has been shown to increase peak responses and time to fatigue during arm ergometry exercise tests.
This study is designed as a prospective, single-center, randomized controlled trial to examine whether and how TSES might alter exercise responses in two groups of people with SCI (tetraplegia and paraplegia) and a reference control group from the general population. The study is designed to assess within individual and between-group responses for a variety of outcome measures during peak and steady-state exercise tests. Study visits occur over several weeks for each participant, according to each person's time and convenience availability.
Outcomes are assessed during exercise with and without TSES in the following 4 experimental conditions:
The primary hypothesis is that TSES will improve a variety of exercise outcomes under different experimental testing conditions and that those with tetraplegia will benefit most.
The results of this study are expected to contribute to whether and how TSES might alter acute exercise responses in those living with SCI.
The results of this study are expected to contribute to the evidence base regarding the effectiveness of TSES to alter peak and steady-state exercise responses in people with SCI and may support its integration into standard exercise training or competitive sport protocols for individuals with SCI.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
TSES will typically involve constant current rectangular pulse bipolar stimulation delivered at 20 Hz with stimulation durations of 900 microseconds delivered at or slightly above motor threshold.
Time frame: During individual study visits lasting between 1 and 2.5 hours
Oxygen uptake, in mL/min
Time frame: Tested intermittently during individual voluntary exercise study visits lasting between 1 and 2.5 hours
Ratings of perceived exertion, on a Borg scale of 6 to 20 with 6 being resting to 20 which is very very hard.
Time frame: Time to fatigue will be monitored during study visits lasting between 1 and 2.5 hours.
Does TSES alter time to fatigue during NMES-evoked rhythmic lower limb exercise, measured in seconds.
Time frame: During exercise testing study visits, lasting between 1 and 3 hours
Heart rate, beats per minute
Time frame: During exercise in study visits lasting 1 to 3 hours.
Watts
Time frame: Oxygen saturation levels will be assessed during study visits lasting between 1 and 2.5 hours.
Does TSES alter muscle tissue oxygen saturation levels during exercise, expressed as a percentage.
Contact information is provided by the study sponsor or research team.
Kristine C Cowley, PhD
CONTACT
Rodrigo Villar, PhD
CONTACT
University of Manitoba
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06690372
Behavior, Central Nervous System Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06295146
Central Nervous System Diseases, Nervous System Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07269977
Central Nervous System Diseases, Disabled Veterans
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06845904
Central Nervous System Diseases, Nervous System Diseases
Lausanne, Canton of Vaud, Switzerland
View Trial Details